Recent studies of the group of hemolytic streptococci associated with scarlet fever indicate that the individual strains are closely related antigenically. These organisms are present in the early stages of the disease in the throats of practically all individuals suffering from scarlet fever. In addition, the specific streptococcus has been isolated from the uterine secretions in an undoubted instance of ISuerperal scarlet fever, from the wound in a ease of wound scarlet, and from the local lesion in an instance of scarlet fever due to infection of a burn. More recently we have been able to obtain this streptococcus from the infected milk and from patients in a milkborne epidemic of scarlet fever. The apparent specificity of the organism and its constant association with the disease again bring into prominence the question of its etiological relationship to scarlet fever. The main objections of Jochmann to this etiological significance, namely that hemolytic streptococci are not present in all cases of scarlet fever, and that the type of streptococcus present is indistinguishable from hemolytic streptococci obtained from other pathological processes, can no longer be maintained.
The importance of a continued effort to decide the significance of this association of streptococcus with scarlet fever is obvious. We have therefore continued the studies just mentioned with the hope of discovering additional evidence. It is probably of fundamental importance to determine beyond question the specificity of the type of streptococcus found in scarlet fever. Up to the present time chief reliance has been placed upon the agglutination reaction as a test of specific serological relationship. This reaction while serviceable is especially likely for a variety of reasons previously discussed to furnish questionable results when used in the study of Streptococcus h6emolyticus. The low virulence of the streptococcus for test animals interferes with cross-protection experiments so that this method cannot be used. In the present study we have again employed the agglutination reaction and have attempted to confirm the results so obtained by determining the capacity of the strains under observation to absorb agglutinin specifically.
Material and Methods.--The strains of Streptococcus hcemolyticus
used in the present study were collected from a variety of widely separated localities. The majority were obtained from the throats of patients in the scarlet fever wards of the Willard Parker Hospital, New York. A number of strains came from an outbreak of scarlet fever due to infected milk. This series includes a strain obtained from the suspected milk supply. In addition a small number of cultures from Copenhagen, San Francisco, Chicago, and Baltimore were studied. The cultures were obtained for the most part during the first few days of the disease. Hemolytic streptococcus was present on the plates from the throat secretions in 87.5 per cent of the individuals examined. This incidence figure is somewhat lower than that of Bliss (100 per cent) owing probably to the fact that some of the cultures were made later during the course of the disease than is desirable. Previous studies have shown that hemolytic streptococcus is only constantly demonstrable when an examination is made during the first days of an attack of scarlet fever. The technique of cultivation and agglutination was the same as that previously described for Streptococcus hcemol.yticus by Dochez, Avery, and Lancefield and by Bliss.
The immune serum used in these experiments was prepared by inoculating rabbits intravenously first with heat-killed and then with living broth cultures. The serum of each animal was tested for the presence of natural agglutinins with two scarlatinal and two non-scarlatinal strains of streptococcus before immunization was begun. Rabbits possessing natural agglutinins for streptococcus were discarded. The first two series of inoculations were with amounts of heat-killed broth culture varying from 0.5 to 4.0 cc.
Each series consisted of four inoculations and an interval of 4 days was allowed to elapse between courses. The third and fourth series consisted of similar inoculation with living 18 hour broth cultures. If the animal lbst weight during the process of immunization it was necessary to decrease the dosage. About 10 days after the last inoculation the animals were bled and the agglutinin titer of the serum determined. The agglutinins in antiscarlatinal sera tend to deteriorate rapidly and this deterioration is greatly accelerated by inactivation at 56°C. The most clear-cut reactions are obtained when freshly prepared serum is used in the tests. The agglutinin for the strain used in immunization generally persists longer than that for other scarlatinal strains. On the other hand, the homologous reaction sometimes tends to diminish at a time when the serum still agglutinates heterologous scarlatinal strains strongly. In all probability this is due to the gradual loss of the agglutinable properties of the strain itself. Very few reactions in which there is any question of specificity occur when sera are prepared and used in the m~nner described. The results of the study of the agglutination reactions of the strains described are presented in Table I . Table I is an arrangement of the agglutination reactions with strains of hemolytic streptococci obtained from cases of scarlet fever occurring in New York (N Y 1, 2, 3, 4 and 5), San Francisco (S F 1 and 2), Chicago (Chi 1 and 2), Baltimore (Bait 1), and Copenhagen, Denmark (Den 1 and 2), during the winter of 1922-23. Through the courtesy of the New York State Department of Health we are able to include reactions with strains isolated from the throats of patients and from milk (E 2340 to E 2406, and E 2950) during a milkborne epidemic of scarlet fever. Strains V 1 and V 2 isolated from throat cultures of patients during the Boston epidemic of septic sore throat were obtained from The Rockefeller Institute for Medical Research. All these strains except Strain E 2950, the milk strain, were obtained from throat cultures. Strains of pyogenic cocci, A, B, C,D, E, F, and G, are non-scarlet strains isolated from infected wounds.
These strains are arranged with the corresponding immune sera in groups according to the sources from which they were obtained.
BIOLOGY OF STREPTOCOCCUS. III
Each reaction, represented by one of the numerals 1, 2, 3, or the letter C., is the result obtained by agghtinating with two immune sera. 
Cross-Agglutination of Strains of Streptococci Isolated from Clinical Cases of Scarlet
Fever.
Sera.
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E
c.
C.
C.
C. Completely negative reactions are indicated by zeros. When no agglutination reaction was carried out with certain sera and strains in the cross-agglutination table, the fact has been noted by a minus sign. No reactions are included in the table in which the control tubes show more than a + reaction in a 1:80 dilution of normal rabbit serum. These streptococcal immune sera are found to agglutinate all of the scarlet strains and with the exception of Serum N Y 1, no agglutination occurs with strains of pyogenic cocci. These reactions confirm the previously reported work of Dochez and Bliss (1), Bliss (2), Gordon (3), and Tunnicliff (4), and substantiate their claim that strains of hemolytic streptococci obtained from scarlatina differ biologically from pyogenic streptococci. On account of the wide distribution of the cases from which these strains were obtained, we believe that this group of streptococci is generally associated with scarlet fever, and that the streptococci with which these authors worked are identical.
Considerable importance is attached to the agglutination of Strains E 2340 to E 2950 since they were obtained both from patients and from the milk during a milk-borne epidemic of scarlet fever. We find that these strains are agglutinated by sera prepared by immunizing animals with other scarlet strains and that sera prepared with these strains agglutinate other streptococci of the scarlatinal group. These reactions identify them as scarlatinal strains and indicate that milk may be a source of contagion in scarlet fever. Strains V 1 and V 2 do not agglutinate with any of the sera, showing that epidemics of streptococcus angina although they are spread through milk infection are caused by a streptococcus differing biologically from Streptococcus scarlatin¢.
These strains obtained from the two epidemics all have a final hydrogen ion concentration of less than pH 5.1, indicating an infection of the milk with human rather than bovine strains. The antigenic properties of these strains vary greatly. Certain strains, such as N Y 4 and 5, when used for immunization, always produce sera which agglutinate scarlatinal strains strongly, while other strains such as Chi 2 have given poor or mediocre sera. Certain strains likewise agglutinate more readily and more heavily than others of the group. For example, Chi 2, which has poor immunizing qualities, is agglutinated more strongly than any other strain. Aside trom these permanent variations in the antigenic properties strains at times become inagglutinable. This occurs especially after a number of transfers in broth. A number of the 0 reactions in the table can be explained in this way. These inagglutinable strains are still capable of stimulating the production of specific agglutinins in animals.
We have found that certain combinations of sera and strains are necessary for the successful absorption of agglutinin. These combinations can usually be picked out by the speed of the reaction and the degree of agglutination. Strains will absorb the agglutinin from sera which are fresh if the agglutination is complete within 15 minutes at 55°C.
By selecting sera and strains which have reacted vigorously we have been able to obtain a series of absorption tests in which every strain is represented. The serum is diluted 1:40 and absorbed twice at 55°C. with the centrifuged bacteria from 250 cc. of culture. In Tables II to VII the results have been tabulated with the series of dilutions, showing the results of agglutination of a serum and the antigenic strain with the serum after heating at 55°C. and after absorption with scarlet and non-scarlatinal streptococci. 
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